More News on Genetic Screening for Prostate Cancer Involving BRCA1 and BRCA2 Genes Among Others.

It is widely accepted that selected genetic screening is the future of prostate cancer detection. Two interesting articles were recently published describing such screening involving the aggressive breast cancer genes, BRCA1 and BRCA2 among others (CHEK2, PALB2 and ATM). For details, see the following link. In addition, researchers in the United Kingdom have determined that advanced prostate cancer can been linked to mutations in eight genes.